Antinuclear antibody-negative systemic sclerosis

Seminars in Arthritis and Rheumatism

Volumn 44, Issue 6, 2015, Pages 680-686

  Salazar, Gloria A ^a   Assassi, Shervin ^a   Wigley, Fredrick ^b   Hummers, Laura ^b   Varga, John ^c   Hinchcliff, Monique ^c   Khanna, Dinesh ^d   Schiopu, Elena ^d   Phillips, Kristine ^d   Furst, Daniel E ^e   Steen, Virginia ^f   Baron, Murray ^g   Hudson, Marie ^g   Taillefer, Suzanne S ^g   Pope, Janet ^h   Jones, Niall ⁱ   Docherty, Peter ^j   Khalidi, Nader A ^k   Robinson, David ^l   Simms, Robert W ^m   Silver, Richard M ⁿ   Frech, Tracy M ^o   Fessler, Barri J ^p   Molitor, Jerry A ^q   Fritzler, Marvin J ^r   Segal, Barbara M ^q   Al Kassab, Firas ^s   Perry, Marilyn ^a   Yang, Jeremy ^a   Zamanian, Sara ^t   Reveille, John D ^a   Arnett, Frank C ^a   Pedroza, Claudia ^a   Mayes, Maureen D ^a   more..

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^g MCGILL UNIVERSITY   (Canada)

^h UNIVERSITY OF WESTERN ONTARIO   (Canada)

ⁱ UNIVERSITY OF ALBERTA   (Canada)

^j MONCTON HOSPITAL   (Canada)

^k MCMASTER UNIVERSITY   (Canada)

^l UNIVERSITY OF MANITOBA   (Canada)

^m BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^o UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^q UNIVERSITY OF MINNESOTA   (United States)

^r UNIVERSITY OF CALGARY   (Canada)

^s UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^t CASE WESTERN RESERVE UNIVERSITY   (United States)

more..

Author keywords

ANA; Antinuclear antibody; Negative; Scleroderma; Systemic sclerosis; Vasculopathy

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADULT; CASE CONTROL STUDY; COMPLICATION; FEMALE; HUMAN; HYPERTENSION, PULMONARY; IMMUNOLOGY; KIDNEY DISEASES; LUNG; LUNG DIFFUSION CAPACITY; MALABSORPTION SYNDROMES; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PULMONARY FIBROSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SKIN ULCER; SYSTEMIC SCLEROSIS; TELANGIECTASIS;

ADULT; ANTIBODIES, ANTINUCLEAR; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION, PULMONARY; KIDNEY DISEASES; LUNG; MALABSORPTION SYNDROMES; MALE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SEX FACTORS; SKIN ULCER; TELANGIECTASIS;

EID: 84921302446     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2014.11.006     Document Type: Article

References (27)

1. Ho K.T., Reveille J.D. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 2003, 5:80-93.
2. Hamaguchi Y. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. J Dermatol 2010, 37:42-53.
3. Steen V.D. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005, 35:35-42.
4. Arnett F.C. Is scleroderma an autoantibody mediated disease?. Curr Opin Rheumatol 2006, 18:579-581.
5. Mayes M.D. The establishment and utility of a population-based registry to understand the epidemiology of systemic sclerosis. Curr Rheumatol Rep 2000, 2:512-516.
6. Hudson M., Satoh M., Chan J.Y., Tatibouet S., Mehra S., Baron M., et al. Prevalence and clinical profiles of 'autoantibody-negative' systemic sclerosis subjects. Clin Exp Rheumatol 2013, 32(6 Suppl 86):S-127-S-132.
7. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980, 23:581-590.
8. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T.A., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
9. Steen V.D., Mayes M.D., Merkel P.A. Assessment of kidney involvement. Clin Exp Rheumatol 2003, 21:S29-S31.
10. Galie N., Hoeper M.M., Humbert M., Torbicki A., Vachiery J.L., Barbera J.A., et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009, 30:2493-2537.
11. Hsu V.M., Moreyra A.E., Wilson A.C., Shinnar M., Shindler D.M., Wilson J.E., et al. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization. J Rheumatol 2008, 35:458-465.
12. Hamaguchi Y., Hasegawa M., Fujimoto M., Matsushita T., Komura K., Kaji K., et al. The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis. Br J Dermatol 2008, 158:487-495.
13. Mierau R., Moinzadeh P., Riemekasten G., Melchers I., Meurer M., Reichenberger F., et al. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features. Arthritis Res Ther 2011, 13:R172.
14. Shah A.A., Wigley F.M., Hummers L.K. Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension. J Rheumatol 2010, 37:98-104.
15. Nihtyanova S.I., Schreiber B.E., Ong V.H., Rosenberg D., Moinzadeh P., Coghlan J.G., et al. Prediction of pulmonary complications and long term survival in systemic sclerosis. Arthritis Rheumatol 2014, 66(6):1625-1635.
16. Steen V.D., Lucas M., Fertig N., Medsger T.A. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody. J Rheumatol 2007, 34:2230-2235.
17. Kampolis C., Plastiras S., Vlachoyiannopoulos P., Moyssakis I., Tzelepis G. The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis. Scand J Rheumatol 2008, 37:278-283.
18. Herrick A.L., Moore T.L., Murray A.K., Whidby N., Manning J.B., Bhushan M., et al. Nail-fold capillary abnormalities are associated with anti-centromere antibody and severity of digital ischaemia. Rheumatology (Oxford) 2010, 49:1776-1782.
19. Arnett F.C., Gourh P., Shete S., Ahn C.W., Honey R.E., Agarwal S.K., et al. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis 2010, 69:822-827.
20. Mayes M.D. The genetics of scleroderma: looking into the postgenomic era. Curr Opin Rheumatol 2012, 24:677-684.
21. Agarwal S.K., Reveille J.D. The genetics of scleroderma (systemic sclerosis). Curr Opin Rheumatol 2010, 22:133-138.
22. Feghali-Bostwick C., Medsger T.A., Wright T.M. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 2003, 48:1956-1963.
23. Assassi S., Arnett F.C., Reveille J.D., Gourh P., Mayes M.D. Clinical, immunologic, and genetic features of familial systemic sclerosis. Arthritis Rheum 2007, 56:2031-2037.
24. Fritzler M.J., Valencia D.W., McCarty G.A. Speckled pattern antinuclear antibodies resembling anticentromere antibodies. Arthritis Rheum 1984, 27:92-96.
25. Cozzani E., Drosera M., Riva S., Parodi A. Analysis of a multiple nuclear dots pattern in a large cohort of dermatological patients. Clin Lab 2012, 58:329-332.
26. Assassi S., Fritzler M.J., Arnett F.C., Norman G.L., Shah K.R., Gourh P., et al. Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol 2009, 36:2250-2256.
27. Zuchner D., Sternsdorf T., Szostecki C., Heathcote E.J., Cauch-Dudek K., Will H. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis. Hepatology 1997, 26:1123-1130.